Market research future published a
half-cooked research report on Middle East and Africa Anti-fungal agents
market. The Middle East and Africa Anti-fungal agents market is expected to
grow at a CAGR of 3.5% during the period 2016 to 2022.
Market Highlights
Anti-fungal agents are used in the
treatment of infections caused by fungus. According to global action fund for
fungal infection, globally, over 300 million people of all ages suffer from a
serious fungal infection every year. The market drivers include rising
prevalence of fungal infections, rising awareness, rise of immunity deficient
population such as geriatrics, rise in exposure to infectious agents due to
environmental factors such as pollution especially by particulates and
agriculture residues and climatic conditions such as humidity and temperature,
occupational hazards such as Jock itch, crowding etc. Growth of fungal
infection due to off label use of broad spectrum antibiotics is a prime factor
for the growing market for anti-fungal agents.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/2582
The market restraints include rising
resistance to anti-fungal agents, use of air filters and air conditioning,
excellent spectrum and efficacy of Azole class of anti-fungal agents, loss of
patents and genericitization etc. Competition by generics is exceptionally
strong and generics account for roughly 50% of total sales for anti-fungal agents.
The market penetration is very easy as there has been loss of patents of block
buster drugs. Over the counter drugs are an important reasons for the growth of
anti-fungal agents market.
The Middle East and Africa anti-fungal
agents market is segmented into therapeutic indication which is further
segmented into aspergillosis, dermatophytosis, candidiasis and others. On the
basis of drug class the sub-segments are azoles, pyrimidines, echinocandins,
polyenes, allylamines, and others. By route of administration the market is
further divided into oral, local and others.
The market for Middle East and Africa
anti-fungal agents is extremely fragmented with a number of small and big
players. The market is also affected by substandard and counterfeit products especially
in poorer regions of Africa with weak regulatory framework. Product development
especially for resistant fungal infections has the highest potential among all
the strategies.
Key Players:
The major participants of this market
are: Novartis AG, Pfizer, Inc., Sanofi-Aventis, Merck & Co., Inc., Enzon
Pharmaceuticals, Inc., Bayer AG, Astellas Pharma, Inc., GlaxoSmithKline plc,
Abbott, Sigma-Aldrich and others
Middle East and Africa Anti-Fungal
Agents Market:
The Middle East and Africa Anti-fungal drugs market has
been evaluated as a growing market and it is expected that the market will grow
at a moderate CAGR in future. The Middle East and Africa Anti-fungal agents
market is expected to grow with CAGR of ~3.5% during the forecast period. The
growth will be primary channeled by the need of unmet medical needs, rising
incomes of the population and the high prevalence of fungal infection in
Africa. Environmental factors such as high humidity and temperature along with
the rich biodiversity of Africa will positively affect the market growth of
anti-fungal agents.
Regional Analysis:
Depending on geographic region,
anti-fungal agents market is segmented into following countries: UAE, Egypt,
Saudi Arabia, Kuwait, Qatar and Oman. UAE is the largest market followed by
Egypt. However the future market will be led by the poor developed parts of
Africa due to large unmet needs and the seasonal climatic conditions of Africa.
The eastern parts of Africa is expected to have greater market share as
compared to the hot and dry western coast.
Segmentation:
Middle East and Africa anti-fungal
agents market has been segmented on the basis of therapeutic indication which
comprises into aspergillosis, dermatophytosis, candidiasis and others. On the
basis of drug class; market is segmented into azoles, pyrimidines,
echinocandins, polyenes, allylamines, and others. On the basis of route of
administration; market is segmented into oral, local and others.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/mea-anti-fungal-agents-market-2582
No comments:
Post a Comment